…
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
WELL Health Technologies Corp is a Canadian digital health company that provides electronic medical records, telemedicine, billing and practice-management software while also owning and operating outpatient clinics. Long-term growth drivers include broader healthcare digitization, rising telehealth adoption, recurring SaaS and services revenue and consolidation opportunities in a fragmented primary-care market that may benefit scale and cross-selling. Investors may find the company attractive for its multi-channel platform exposure to outpatient care efficiency and recurring revenue characteristics and because it appears positioned to capture continued digital adoption.
Key risks include execution and integration challenges from acquisitive growth, regulatory and patient-privacy compliance exposure, competitive pressure from larger health IT vendors, and sensitivity to reimbursement and funding changes, which investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 5.31M | 8.99M | 19.88M | 17.92M | -24.77M |
| Minority interest | -11.82M | 3.51M | -16.55M | -17.31M | -12.89M |
| Net income | -50.21M | 32.61M | 0.08M | 19.07M | -30.69M |
| Selling general administrative | 339.87M | 321.47M | 212.69M | 176.41M | 107.75M |
| Selling and marketing expenses | 92.51M | - | 64.29M | 47.70M | 15.78M |
| Gross profit | 525.08M | 363.01M | 311.50M | 303.29M | 153.69M |
| Reconciled depreciation | 93.76M | 72.31M | 60.77M | 55.20M | 38.22M |
| Ebit | 113.03M | - | 41.11M | 22.11M | -6.70M |
| Ebitda | 206.79M | - | 101.88M | 77.31M | 32.01M |
| Depreciation and amortization | 93.76M | - | 60.77M | 55.20M | 38.71M |
| Operating income | 113.03M | -54.88M | 41.11M | 23.31M | -6.21M |
| Other operating expenses | 1287.15M | - | 734.95M | 545.15M | 310.37M |
| Interest expense | 54.47M | 0.57M | 31.34M | 22.34M | 7.55M |
| Tax provision | 0.85M | -20.10M | 2.86M | -1.15M | 5.92M |
| Interest income | 1.72M | 61.53M | 0.76M | 0.65M | 2.20M |
| Net interest income | -56.16M | -35.61M | -31.56M | -22.21M | -7.26M |
| Income tax expense | 0.85M | - | 2.86M | -1.15M | 5.92M |
| Total revenue | 1400.18M | 919.69M | 776.05M | 569.14M | 302.32M |
| Total operating expenses | 412.05M | 950.45M | 270.39M | 279.31M | 161.74M |
| Cost of revenue | 875.10M | 556.68M | 464.56M | 265.85M | 148.63M |
| Total other income expense net | -107.72M | 75.37M | -21.23M | -5.39M | -18.56M |
| Net income from continuing ops | 4.46M | 29.10M | 16.64M | 18.68M | -30.89M |
| Net income applicable to common shares | - | 32.61M | 0.08M | 1.37M | -43.79M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2096.89M | 1807.27M | 1409.30M | 1319.03M | 1262.42M |
| Intangible assets | 760.21M | 573.96M | 555.20M | 571.27M | 405.52M |
| Other current assets | 30.76M | 1.68M | 21.58M | 0.52M | 3.68M |
| Total liab | 1057.49M | 877.55M | 563.16M | 503.78M | 554.37M |
| Total stockholder equity | 863.51M | 867.61M | 767.67M | 732.34M | 618.24M |
| Other current liab | 106.84M | 8.64M | 37.45M | 35.72M | 75.69M |
| Common stock | 808.06M | - | 751.55M | 705.19M | 633.51M |
| Capital stock | 808.06M | 784.87M | 751.55M | 705.19M | 633.51M |
| Retained earnings | -38.34M | -30.98M | -63.58M | -63.67M | -64.64M |
| Other liab | - | - | - | 52.12M | 72.51M |
| Good will | 787.62M | 565.12M | 508.06M | 499.29M | 611.75M |
| Other assets | - | - | - | 3.18M | 2.85M |
| Cash | 133.75M | 131.67M | 43.42M | 48.91M | 61.92M |
| Cash and equivalents | - | - | - | 48.91M | 61.92M |
| Total current liabilities | 357.47M | 382.08M | 152.95M | 136.50M | 137.30M |
| Current deferred revenue | 49.41M | - | 6.65M | 6.80M | 4.24M |
| Net debt | 577.21M | 213.69M | 382.86M | 309.51M | 340.02M |
| Short term debt | 109.62M | - | 60.98M | 43.26M | 57.37M |
| Short long term debt | 89.94M | 9.38M | 46.11M | 34.15M | 50.15M |
| Short long term debt total | 710.96M | - | 426.28M | 358.42M | 401.94M |
| Other stockholder equity | - | - | 54.05M | 51.77M | 43.99M |
| Property plant equipment | - | - | - | 82.53M | 88.55M |
| Total current assets | 369.61M | 346.11M | 176.40M | 150.88M | 142.91M |
| Long term investments | 19.04M | 173.79M | 60.86M | 10.01M | 10.85M |
| Net tangible assets | - | - | - | -338.21M | -399.03M |
| Net receivables | 202.62M | 184.50M | 110.21M | 95.85M | 71.82M |
| Long term debt | 420.65M | 335.98M | 298.91M | 263.00M | 290.60M |
| Inventory | 2.46M | 2.69M | 1.18M | 1.37M | 0.79M |
| Accounts payable | 91.60M | 86.58M | 47.88M | 50.73M | 38.67M |
| Accumulated other comprehensive income | 93.78M | - | 25.65M | 39.06M | 5.38M |
| Non currrent assets other | 7.74M | 3.54M | 4.39M | 5.06M | 2.85M |
| Non current assets total | 1727.28M | 1461.16M | 1232.91M | 1168.15M | 1119.52M |
| Capital lease obligations | 90.05M | 79.73M | 81.26M | 61.26M | 61.19M |
| Long term debt total | - | - | - | 315.16M | 344.57M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -60.23M | -81.31M | -37.93M | -3.12M |
| Change to liabilities | - | - | - | 10.14M | 1.20M |
| Total cashflows from investing activities | -111.74M | -60.23M | -81.31M | -37.93M | -499.78M |
| Net borrowings | 73.62M | - | - | -58.75M | 171.07M |
| Total cash from financing activities | 0.94M | 133.50M | 39.58M | -52.85M | 452.53M |
| Change to operating activities | - | - | - | -6.74M | 0.21M |
| Net income | -7.36M | 29.10M | 0.08M | 18.68M | -30.89M |
| Change in cash | -131.67M | 88.25M | -5.49M | -13.01M | -24.97M |
| Begin period cash flow | 131.67M | 43.42M | 48.91M | 61.92M | 86.89M |
| End period cash flow | 133.75M | 131.67M | 43.42M | 48.91M | 61.92M |
| Total cash from operating activities | 115.79M | 10.22M | 62.59M | 76.55M | 22.27M |
| Issuance of capital stock | 58.32M | 47.65M | 0.00M | 34.51M | 302.50M |
| Depreciation | 93.76M | 72.31M | 60.77M | 55.20M | 38.22M |
| Other cashflows from investing activities | -91.53M | -44.00M | -73.21M | -31.52M | -25.54M |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | 0.23M | -1.51M | 0.19M | -0.58M | 0.88M |
| Change to account receivables | 47.30M | - | -2.48M | -9.37M | -13.27M |
| Sale purchase of stock | -1.83M | 49.21M | 0.81M | -0.24M | 303.13M |
| Other cashflows from financing activities | -155.28M | 133.63M | -25.10M | 21.10M | 191.22M |
| Change to netincome | - | - | - | - | 37.86M |
| Capital expenditures | 27.87M | 16.23M | 25.38M | 6.40M | 2.68M |
| Change in working capital | -36.70M | 6.67M | -10.25M | -6.06M | -11.20M |
| Stock based compensation | 22.69M | 15.27M | 26.16M | 24.48M | 21.01M |
| Other non cash items | 82.47M | 20.84M | -3.75M | -14.78M | 4.09M |
| Free cash flow | 87.92M | -6.70M | 37.20M | 70.14M | 19.59M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WELL WELL Health Technologies Corp |
0.06 1.45% |
4.20 | - | 13.87 | 0.80 | 1.23 | 1.09 | 9.83 |
| EXE Extendicare Inc |
0.23 0.81% |
28.52 | 25.21 | 23.92 | 1.59 | 7.26 | 1.62 | 14.43 |
| SIA Sienna Senior Living Inc |
0.13 0.64% |
20.36 | 45.94 | 38.17 | 2.23 | 3.17 | 3.57 | 21.90 |
| DR Medical Facilities Corporation |
0.08 0.53% |
15.12 | 15.57 | 12.94 | 1.18 | 2.87 | 0.92 | 3.64 |
| AIDX HealWELL AI Inc. |
0.01 1.52% |
0.67 | - | - | 2.81 | 2.35 | 3.46 | -4.93 |
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Hamed Shahbazi B.Sc., BSc | Founder, Chairman & CEO | 1975 |
| Ms. Eva Fong | Chief Financial Officer | NA |
| Mr. Amir Javidan | Chief Operating Officer | NA |
| Mr. Brian Eric Levinkind | Sr. VP of Corp. Devel. | 1966 |
| Dr. Michael Frankel | Chief Medical Officer | NA |
| Mr. Arjun Kumar | Chief Information Officer | NA |
| Mr. Pardeep S. Sangha M.B.A. | VP of Corp. Strategy & Investor Relations | NA |
| Mr. Chris Ericksen | Sr. VP of Strategic Partnerships & Marketing | NA |
| Mr. Shane Joseph Sabatino | Chief People Officer | NA |
| Ms. Sara Bond | Sr. VP of Product Devel. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.